Could Parkinson’s disease begin in the skin?

Professor Per Borghammer and Associate Professor Nathalie Van Den Berge from the Department of Clinical Medicine will investigate whether environmental toxicants could contribute to the onset of Parkinson’s disease through the nervous system in the skin. The project has received DKK 80 million from the European Research Council.

Associate Professor Nathalie Van Den Berge, Professor Avraham Ashkenazi from Tel Aviv University and Professor Per Borghammer will investigate whether Parkinson’s disease could begin in the skin.
Associate Professor Nathalie Van Den Berge, Professor Avraham Ashkenazi from Tel Aviv University and Professor Per Borghammer will investigate whether Parkinson’s disease could begin in the skin. Photo: DERMIS-PD.

Parkinson’s disease is primarily associated with the brain and the movement problems that develop as the disease progresses. But the earliest changes in the nervous system may begin many years earlier – and perhaps in an entirely different part of the body.

With a major new EU grant, Professor Per Borghammer and Associate Professor Nathalie Van Den Berge from the Department of Clinical Medicine at Aarhus University will join forces with Professor Avraham Ashkenazi from Tel Aviv University to investigate whether Parkinson’s disease could, in some cases, begin in the skin.

The researchers will investigate whether environmental toxicants, such as pesticides and industrial solvents, can trigger disease-related changes in nerve endings in the skin, potentially setting Parkinson’s disease in motion.

“Parkinson’s disease begins many years before the first movement symptoms appear. By understanding how environmental exposures interact with the vulnerability of specific nerve cells, we hope to uncover the earliest mechanisms of the disease and open new possibilities for early detection and prevention,” say the researchers behind the project.

To test their hypothesis, the researchers will combine animal models, patient studies and studies of nerve cells derived from human stem cells. The aim is to gain a better understanding of how the disease begins and what role environmental exposures may play.

The project, DERMIS-PD, has received an ERC Synergy Grant of DKK 80 million from the European Research Council. Of this, just over DKK 52 million will go to Aarhus University.

Contact

Professor Per Borghammer
Aarhus University, Department of Clinical Medicine - PACE
Email: borghammer@clin.au.dk

Associate Professor Nathalie Van Den Berge
Aarhus University, Department of Clinical Medicine - Centre for Molecular Morphology and PACE
Email: nathalie.vandenberge@clin.au.dk